Contingency Management for Meth Addiction

Because no medication has been approved for methamphetamine use disorder, behavioral treatments carry the full clinical weight of recovery. Of all behavioral interventions studied, contingency management has the strongest evidence base for stimulants. SAMHSA’s 2024 clinical advisory (PEP24-06-001) identifies CM as one of the most effective treatments for stimulant use disorder. A meta-analysis of 47 randomized controlled trials published in Addiction (Prendergast et al., 2006) found CM participants achieved significantly more drug-free weeks and better treatment retention than those in standard care alone.

For meth specifically, where relapse rates are high and medication is not an option, that evidence is decisive. What the research consistently shows: retention — CM participants stay in treatment significantly longer, the single strongest predictor of long-term recovery outcomes; abstinence — more consecutive clean drug tests during the critical first months; relapse intervals — longer periods of sobriety that reinforce habits outlasting the incentive structure itself; and co-occurring conditions — CM remains effective even when depression or anxiety co-occurs with meth use.

CM is transparent and structured from the beginning. You and your clinical team agree on specific, achievable goals, most commonly negative drug tests and consistent attendance. Each time you meet a goal, you earn an incentive. The reward value can increase as your streak of clean days grows. Your goals, testing schedule, and incentive structure are agreed upon at intake and reviewed as your recovery progresses.

The incentives are not the destination. They are a bridge through the hardest stretch of meth recovery, when cravings are sharpest and the rewards of sober life have not yet come back online, until sobriety starts to feel worth it on its own terms. CM is particularly suited to people who have experienced relapse after prior treatment attempts, struggle with motivation when natural rewards feel flat in early sobriety, or have co-occurring depression making it difficult to feel rewarded by progress.

Contingency management works best as part of a complete treatment plan, not in isolation. At iRely Recovery, we pair it with the Matrix Model, the NIDA-recognized 16-week intensive outpatient program built specifically for stimulant recovery; cognitive behavioral therapy (CBT) for trigger mapping, urge-surfing, and relapse-prevention skills; and dual-diagnosis care for the depression, anxiety, or trauma that often co-occurs with meth use.

CM provides the motivation to stay engaged. The Matrix Model provides the structure over 16 weeks. CBT provides the tools for what comes after. Together, they address meth’s impact on brain, behavior, and daily life simultaneously rather than sequentially. Because meth use so often travels with depression, anxiety, or trauma, our integrated dual-diagnosis approach treats those conditions in parallel rather than waiting until sobriety is stable to address them.